Moderna CEO brazenly defends 400% COVID shot price hike, downplays NIH’s role
Published
In Congressional testimony Wednesday, Moderna CEO Stéphane Bancel unabashedly defended the company's plans to raise the US list price of its COVID-19 vaccines by more than 400 percent—despite creating the vaccine in partnership with the National Institutes of Health, receiving $1.7 billion in…
#congressional #stéphanebancel #sanders #bancel #nih